GlassScriptPhysician profile
Ronald Sockolov
NPI 1871531699
$14,445.61
in general payments reported to CMS, 2019-2025
72 companies · $2,008 in 2025
The $2,008 reported for 2025 was more than what 95% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,111 · 2020: $1,758 · 2021: $2,399 · 2022: $2,214 · 2023: $2,139 · 2024: $1,816 · 2025: $2,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,963.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,346.79 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $1,292.73 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,076.45 | 2019-2025 | Spravato, Xarelto |
| Abbvie INC. | $1,005.75 | 2019-2025 | Linzess, Ubrelvy, Viberzi |
| Lilly USA, LLC | $976.87 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $898.35 | 2019-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $871.82 | 2019-2025 | Jardiance, Ofev |
| Merck Sharp & Dohme LLC | $628.76 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $514.90 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $491.64 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $342.80 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $305.38 | 2021-2024 | |
| Gilead Sciences, INC. | $218.21 | 2022-2025 | |
| Allergan, INC. | $189.45 | 2020 | |
| Mannkind Corporation | $183.68 | 2019-2021 |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $176.06 | 2020-2021 | |
| Therapeuticsmd, INC. | $167.48 | 2019-2022 | |
| Exact Sciences Corporation | $159.85 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $141.29 | 2022 | |
| Vanda Pharmaceuticals INC. | $137.77 | 2019-2022 | |
| Abbott Laboratories | $135.00 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astellas Pharma US INC | $131.90 | 2019-2023 | Veozah |
| Esperion Therapeutics, INC. | $131.08 | 2020-2021 | |
| Sanofi Pasteur INC. | $127.47 | 2019-2025 | |
| Hologic Sales and Service, LLC | $126.45 | 2019-2025 | Aptima |
| Sumitomo Pharma America, INC. | $124.44 | 2024-2025 | Gemtesa |
| Amgen INC. | $121.14 | 2019-2025 | Evenity, Otezla, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $118.48 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $117.82 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $114.87 | 2024-2025 | |
| Eisai INC. | $114.32 | 2020-2022 | |
| Boston Scientific Corporation | $112.72 | 2019-2025 | General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.01 | 2020-2023 | Xifaxan |
| Agios Pharmaceuticals, INC. | $102.01 | 2024-2025 | Pyrukynd |
| Medtronic, INC. | $96.81 | 2022-2025 | Intellis Adaptivestim, Minimed 780g, Inceptiv |
| Corcept Therapeutics | $91.69 | 2021-2025 | Korlym |
| Amarin Pharma, INC. | $85.73 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $83.42 | 2020-2022 | |
| Phathom Pharmaceuticals, INC. | $82.03 | 2024-2025 | Voquezna |
| Ibsa Pharma INC. | $77.36 | 2020-2022 | |
| Lundbeck LLC | $73.59 | 2020-2025 | Vyepti |
| Dynasplint Systems INC. | $71.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $62.80 | 2022-2023 | Eliquis |
| Seqirus USA INC | $57.31 | 2022-2024 | Fluad Quadrivalent, Flucelvax Quadrivalent, Fluad |
| Bausch Health US, LLC | $56.34 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $52.50 | 2020-2021 | |
| Bioventus LLC | $50.47 | 2019 | |
| Dexcom, INC. | $49.78 | 2023 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $49.11 | 2025 | Symbravo |
| Idorsia Pharmaceuticals US INC | $48.52 | 2023 | Quviviq |
| Novavax INC | $46.28 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Horizon Therapeutics Plc | $44.59 | 2021 | |
| Xeris Pharmaceuticals, INC. | $39.58 | 2025 | Keveyis, Gvoke Hypopen |
| Antares Pharma, INC. | $39.42 | 2022-2024 | Xyosted |
| Hikma Pharmaceuticals USA | $35.41 | 2019 | |
| Nevro Corp. | $33.98 | 2022 | |
| Mylan INC. | $33.90 | 2022 | |
| Medtronic USA, INC. | $26.61 | 2019 | |
| Si-Bone, INC. | $25.67 | 2023 | |
| Qiagen, LLC | $22.19 | 2025 | |
| Phadia US INC. | $19.66 | 2023 | Immunocap |
| Alexion Pharmaceuticals, INC. | $19.51 | 2024 | Strensiq |
| Assertio Therapeutics, INC. | $19.12 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $18.76 | 2023 | Prehevbrio |
| Verity Pharmaceuticals INC. | $18.19 | 2024 | Tlando |
| Halozyme INC | $17.59 | 2023 | |
| Organon LLC | $17.03 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.69 | 2021 | |
| Biodelivery Sciences International, INC. | $13.23 | 2020 | |
| Alfasigma USA, INC. | $12.67 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.51 | 2019 | |
| Medicure Pharma INC. | $10.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Sockolov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.